Michael Sarik, DO
Clinical Cardiac Electrophysiology · Mason City, IANPI 1154319358
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Boston Scientific at 49.3% of the total. Reporting peaked in 2019 at $303 and has fallen 65.4% since, to $105 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IA, where the typical reported total is $15,103.
Across 34 payments — averaging $12.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$216
- Biosense Webster, Inc.$84
- Novo Nordisk$79
- Abbott$21
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16
- Novartis$12
- plus $11 from 1 others
What the payments were for
- Food & beverage$439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $216 |
| Biosense Webster, Inc. | 3 | $84 |
| Novo Nordisk | 1 | $79 |
| Abbott | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $16 |
| Novartis | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
How this compares
$439 in reported general payments places this provider in the 10th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
See all clinical cardiac electrophysiology providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 518 | $530,318 |
| XareltoRivaroxaban | 132 | $99,064 |
| EntrestoSacubitril/Valsartan | 29 | $26,196 |
| JardianceEmpagliflozin | 14 | $19,252 |
| Dofetilide | 47 | $16,293 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 93 | $16,114 |
| Metoprolol Succinate | 777 | $14,098 |
| Repatha SureclickEvolocumab | 11 | $8,078 |
| Flecainide Acetate | 159 | $6,309 |
| Droxidopa | 22 | $3,974 |
| Digoxin | 168 | $2,967 |
| Ranolazine ErRanolazine | 39 | $2,666 |
| Atorvastatin Calcium | 249 | $2,425 |
| Nebivolol Hcl | 21 | $2,302 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 73 | $2,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $11 | $99,064132 claims |
| NovartisEntresto | $12 | $26,19629 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
Other clinical cardiac electrophysiology in Mason City
- Michael GiudiciMason City$1K
- Steven MickelsenIowa City$2.4M
- Jason MeyersWest Des Moines$189K
- Mohit ChawlaCedar Rapids$101K
- Paari DominicIowa City$83K
- Nilarun ChowdhuriDavenport$73K
- Peter FarjoIowa City$72K
- Oluwaseun AdeolaIowa City$49K
- Victor AbrichWaterloo$47K
- Steven BailinWest Des Moines$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.